Radyus Research

Were a team of experienced drug developers with pharma R&D and venture capital backgrounds. We know what good looks like to buyers and investors when developing a new drug. Our services are designed to guide our clients to success and expedite drug development. We work with biotech companies, academic startups, and venture capital firms. Most frequently we partner with our clients at a lead optimization and candidate selection stage, through IND-enabling studies and into first in human trials. Our expertise is in immunology, oncology, infectious diseases, metabolic diseases, and neurosciences - across modalities. We manage your program through clinical POC:...

Project management,drug development,preclinical studies,cmc/manufacturing,regulatory,quality,target product profile,product development plan,oncology,immunology,metabolic,cns,infectious diseases,small molecules,adc,antibodies,gene therapy,cell therapy,and clinical trial management

Radyus research operates in the Biotechnology industry.

Radyus research's revenue is 11m - 100m

Radyus research has 11 - 50 employees.